Episoder
-
Join us on the latest episode! Our Guest: Sam Cooper, Co-Founder & CTO at Phenomic.
What you'll get out of this episode:
Sam Cooper shares his journey from Imperial College London to founding Phenomic.Phenomic's innovative approach combines AI with biological research.The company focuses on developing drugs targeting the tumor stroma.Phenomic's partnership with TileDB and Boehringer Ingelheim.Advice for budding biotech entrepreneurs from Sam Cooper.To Learn More About Our Guests and their Companies:
LinkedIn https://www.linkedin.com/in/sam-cooper-537814134/
Company LinkedIn https://www.linkedin.com/company/phenomic/
Website https://phenomic.ai/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ -
Join us on the latest episode! Our Guests: Christine Senn, PhD, the SVP of Site-Sponsor Innovation at Advarra & Rohit Nambisan, Co-Founder and CEO at Lokavant.
What you'll get out of this episode:
Rohit Nambisan discusses Lokavant's approach to leveraging AI in clinical trial feasibility.Christine Senn highlights the importance of thorough feasibility processes in rare disease trials.The need for diverse site participation and data inputs to improve trial accuracy and efficiency.The role of AI and technology in enhancing clinical trial processes.To learn more about our guests and their companies:
Christine's LinkedIn https://www.linkedin.com/in/christinesenn/
Rohit's LinkedIn https://www.linkedin.com/in/rohitnambisan/
Advarra LinkedIn https://www.linkedin.com/company/advarra/
Lokavant LinkedIn https://www.linkedin.com/company/lokavant/Advarra Website https://www.advarra.com/
Lokavant Website https://www.lokavant.com/en-us/Our sponsor for this episode is:
Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ -
Manglende episoder?
-
Join us on the latest episode! Our Guest: Dr. Sam Clark, Founder and CEO at Terran Biosciences.
What you'll get out of this episode:
Revolutionizing Treatments: Dr. Sam Clark discusses Terran Biosciences' mission to innovate treatments for neurological and psychiatric conditions.Innovative Drug Development: The company focuses on creating new mechanisms for treating depression, bipolar disorder, and schizophrenia.Smaller, Agile Teams: Terran Biosciences operates with a flat structure, utilizing highly trained experts to solve complex problems.Addressing Patent Monopolies: The company aims to break patent monopolies in pharma through innovative approaches and pro-drug strategies.Exciting Developments: Dr. Clark teases upcoming announcements, including long-acting and improved drug forms.To learn more about our guests and their companies:
LinkedIn https://www.linkedin.com/in/sam-clark-md-phd-133139199/
Company LinkedIn https://www.linkedin.com/company/terran/
Website https://terranbiosciences.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ -
Join us on the latest episode! Our Guest: Dr. Michael Kyle, SVP & Chief Medical Officer at Currax Pharmaceuticals.
What you'll get out of this episode:
Dr. Michael Kyle's Background: Insights into his journey from medical practice to becoming SVP & Chief Medical Officer of Currax Pharmaceuticals.Understanding Obesity: A discussion on different types of obesity and the importance of tailored treatments.Global Perspectives: Comparing how the U.S. and European countries handle obesity and the lessons to be learned.Evolving Treatments: The parallel evolution of hypertension and obesity treatments.Behavioral Approaches: The importance of sustainable lifestyle changes and behavior modification in addressing obesity.To learn more about our guests and their companies:
LinkedIn https://www.linkedin.com/in/michael-l-kyle/
Company LinkedIn https://www.linkedin.com/company/currax-pharmaceuticals-llc/
Website https://www.curraxpharma.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ -
Join us on the latest episode! Our Guest: Colin Weller, VP & GM of Evidence Platform at Medable.
What you'll get out of this episode:
Introduction of Colin Weller: Vice President and GM of Evidence Platform at Medable, Colin Weller discusses his role in advancing clinical research technology to streamline drug approvals.Challenges in Drug Development: Weller details the stagnant pace of drug development, highlighting the industry's need for innovation to improve efficiency and reduce costs.Medable's Ambitious Goals: Aiming to increase the number of drugs approved annually by tenfold through advanced SAS technology and AI, setting a new industry standard.Innovations in Clinical Trials: Medable has already cut study startup times by 50%, utilizing AI and automation to overhaul traditional processes.Future of Digital Clinical Trials: Weller predicts significant advancements in decentralized and digital trials, enhancing patient accessibility and data quality.To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/colin-weller-294ab58/
Company LinkedIn: https://www.linkedin.com/company/medable-inc-/
Website: https://www.medable.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ -
Join us on the latest episode! Our Guest: Stella K. Vnook, CEO at Likarda.
What you'll get out of this episode:
Stella Vnook, CEO of Likarda, discusses her transition from a science background to the business side of biotech and her journey to becoming CEO.Likarda specializes in core-shell spherification, creating beads with cells for targeted drug delivery, improving viability and efficacy.The company aims to enhance cell therapies, especially in liver cells and hormone therapy, and simplify cell transport logistics.Likarda's future goals include launching off-the-shelf products for osteoarthritis and advancing partnerships in cell therapy and regenerative medicine.Funding strategies and future plans involve a Series A funding round, non-dilutive funding, and efficient use of resources to scale up and innovate.To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/vnook/
Company LinkedIn: https://www.linkedin.com/company/likarda-llc/
Website: https://likarda.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ -
Join us on the latest episode! Our Guest: Samantha Dale Strasser, CEO & Co-Founder at Pepper Bio.
What you'll get out of this episode:
Samantha Dale Strasser, co-founder and Chief Science Officer of Pepper Bio, shares her transition from academia to entrepreneurship, driven by a personal mission to change healthcare outcomes.Pepper Bio, located in Boston, leverages transomics to integrate multiple data sets for precision medicine, aiming to treat diseases that are currently untreatable.Strasser’s focus is on developing treatments for challenging diseases, with an emphasis on oncology, inflammatory diseases, and neurodegenerative disorders.Pepper Bio’s approach in drug discovery combines its own pipeline development with strategic partnerships, speeding up the process of bringing new treatments to the clinic.The company has made significant strides in identifying novel targets and shelved assets, leading to a high success rate in in vivo model validations.To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/samantha-dale-strasser/
Company LinkedIn: https://www.linkedin.com/company/pepperbio/
Website: https://pepper.bio/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ -
Join us on the latest episode! Our Guest: Cary Claiborne, CEO of Adial Pharmaceuticals.
What you'll get out of this episode:
Meet Cary Claiborne: Discover the visionary CEO behind Adial Pharmaceuticals.Understanding AD04: Dive into the science of this promising new treatment for alcohol use disorder.The Impact of Alcohol Use Disorder: A closer look at the challenges and the need for better treatments.A Glimpse into the Future: Explore how AD04 could revolutionize addiction treatment beyond alcohol use disorder.Adial's Mission and Vision: Hear directly from Claiborne about the company's path forward and commitment to innovation.To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/cary-claiborne-sr-84a2217/
Company LinkedIn: https://www.linkedin.com/company/adialpharma/
Website: https://www.adial.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ -
Join us on the latest episode! Our Guest: Marcio Souza, CEO of Praxis Precision Medicines.
What you'll get out of this episode:
Discussion on innovative CNS drug development on BioBreakthroughs podcast.Learn about Praxis' genetics-inspired approach to tackling complex brain diseases.Souza highlights the challenges and opportunities in CNS treatment, including the impactful EMBOLD and EMBRAVE studies.Discover Praxis Precision Medicines' future prospects and their commitment to revolutionizing patient care in the CNS field.To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/marcio-souza-2b02837/
Company LinkedIn: https://www.linkedin.com/company/praxis-precision-medicines-inc/
Website: https://praxismedicines.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ -
Join us on the latest episode! Our Guest: Steve Reed, Co-Founder & Chief Executive Officer Of HDT Bio
What you'll get out of this episode:
Reed shares his 40-year journey in microbiology and immunology.Discussion on HDT Bio's approach to vaccine development for infectious diseases and cancer.Insight into the Amplify vaccine platform and its impact on global health.Reed's perspective on vaccine accessibility and affordability.Preview of HDT Bio's upcoming projects in oncology.To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/steven-reed-b23b159b/
Company LinkedIn: https://www.linkedin.com/company/hdt-bio/
Website: https://www.hdt.bio/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ -
Join us on the latest episode! Our Guest: Gadi Saarony, CEO of Advarra
What you'll get out of this episode:
Discussing the challenges in clinical research and strategies for overcoming them.Exploring the role of technology in modern clinical trials.Advarra's innovative approach to streamlining clinical research processes.Insights on the future of clinical trials and healthcare innovation.Key takeaways from the discussion and implications for the industry.To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/gadi-saarony/
Company LinkedIn: https://www.linkedin.com/company/advarra/
Website: https://www.advarra.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ -
Join us on the latest episode! Our Guest: David Stein, CEO of Babson Diagnostics.
What you'll get out of this episode:
Insightful discussion on innovative blood testing technology.Stein's journey in the healthcare and medtech sectors.Challenges and triumphs in developing new blood testing methods.Future prospects and impact of Babson Diagnostics in healthcare.To learn more about our guests and their companies:
LinkedIn: https://www.linkedin.com/in/david-stein-ceo/
Company LinkedIn: https://www.linkedin.com/company/babsondx/about/
Website: https://www.babsondx.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ -
Join us on the latest episode! Our Guests: Professor Omid Veiseh and Paul Cherukuri, Chief Innovation Officer at Rice University.
What you'll get out of this episode:
The vision and strategies behind the LaunchpadHouston as a key location for medical innovationImpact on the local and national biotech sceneUpcoming projects and future prospects in biotechnologyTo learn more about our guests and their companies:
Omid's LinkedIn: https://www.linkedin.com/in/omid-veiseh-0a545b3/
Paul's LinkedIn: https://www.linkedin.com/in/pcherukuri/
Website: https://www.rice.edu/
Company LinkedIn: https://www.linkedin.com/school/riceuniversity/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ -
Join us on the latest episode! Our Guest: Katie Baca-Motes, Co-Founder And CSO At Scripps Research – Digital Trials And Engagement.
What you'll get out of this episode:
The shift towards decentralized clinical trials.The impact of wearable technology on health monitoring.The role of patient-mediated Electronic Health Records (EHRs).Exploration of AI, wearables, and patient-centric data strategies.Katie Baca-Motes shares her perspectives on the advancements in digital healthcare.To learn more about Katie and Scripps Research and Digital Trials and Engagement:
Guest LinkedIn: https://www.linkedin.com/in/katiebaca/
Website: https://digitaltrials.scripps.edu/
Company LinkedIn: https://www.linkedin.com/school/the-scripps-research-institute/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ -
Join us on the latest episode! Our Guest: Greg Divis, CEO at Avadel Pharmaceuticals
What you'll get out of this episode:
Discussing LUMRYZ, a new narcolepsy drug.Insights into the challenges of narcolepsy treatment.Avadel's future plans in healthcare innovation.To learn more about Greg and Avadel Pharmaceuticals:
Guest LinkedIn: https://www.linkedin.com/in/greg-divis-a525334/
Website: https://www.avadel.com/
Company LinkedIn: https://www.linkedin.com/company/avadelpharmaceuticals/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/ -
Join us on the latest episode! Our Guest: Shankar Musunuri, Chairman, CEO and Co-Founder Ocugen
What you'll get out of this episode:
Dr. Shankar Musunuri of Ocugen discusses gene and cell therapy innovationsFocus on tackling unmet needs in ophthalmology and vaccine developmentInsights into Ocugen's unique platforms and global health impactFuture prospects in biotech and healthcare advancementsTo learn more about Ocugen:
Website: https://www.ocugen.com/
LinkedIn: https://www.linkedin.com/company/ocugen/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/ -
Join us on the latest episode! Our Guest: Jay Srinivasan, CEO of Truvian
What you'll get out of this episode:
Discussing breakthroughs in healthcare diagnosticsInsights on integrating technology in healthcareTruvian's mission: accessible and affordable healthcareFocus on early detection and intervention in medical testingFuture vision for healthcare accessibility and efficiencyTo learn more about Truvian: https://truvianhealth.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/ -
Join us on the latest episode! Our Guest: J.D. Mowery, CEO of KBI Biopharma
What you'll get out of this episode:
Mowery's progression from the chemical industry to biopharma leadership.Exploration of Mowery's experiences in the industry.KBI BioPharma: Insights into the company's impact and role in the biopharmaceutical industry.Discussion on KBI BioPharma's international facilities and outreach.Mowery shares his strategic vision for KBI BioPharma and the evolving CDMO industry.A focus on the importance of customer relationships and collaborative approaches in biopharma.Mowery's thoughts on the future of biopharma and leadership.To learn more about KBI Biopharma: https://www.kbibiopharma.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/ -
Join us on the latest episode! Our Guest: Raj Indupuri, CEO of eClinical Solutions
What you'll get out of this episode:
Learn how AI optimizes clinical trial design and patient recruitmentExplore the impact of AI on reducing drug development costs and timelinesUnderstand the advancements toward personalized medicineDive into the challenges and opportunities of adopting AI in life sciencesGet insights on how other industries have successfully integrated AI and what healthcare can learn from themTo learn more about eClinical Solutions: https://www.eclinicalsol.com/
Our sponsors for this episode are:
Sage Growth Partners https://sage-growth.com/ -
Join us on the latest episode! Our Guest: Rafael Fantauzzi, Chief Diversity, Equity, and Inclusion Officer at Boehringer Ingelheim.
What you'll get out of this episode:
Understanding DEI: Diversity, Equity, and Inclusion explained Cultivating Inclusion: Building trust and embracing inclusive behaviorsCollaborative Success: How collaboration fuels progressStaying Informed: The importance of keeping up with DEI trends and legal developmentsFuture of DEI: Boehringer Ingelheim's vision for a more inclusive futureTo learn more about Boehringer Ingelheim: http://www.boehringer-ingelheim.com
Our sponsors for this episode are:
Sage Growth Partners https://sage-growth.com/ - Vis mere
